Terry Robinson has been appointed executive director of The Catalent Applied Drug Delivery Institute. Ms. Robinson joined Catalent in 2008 as director of Global Accounts, having previously held senior positions with large pharmaceutical companies. She has more than 20 years of experience in the pharmaceutical industry.
Kurt Nielsen Ph.D., senior vice president of R&D at Catalent said, “The appointment of an executive director is significant in strengthening the institute’s ability to foster better collaboration in drug development.”
Established in 2012, the Institute aims to accelerate the adoption of advanced drug delivery technologies through industry and academic collaboration, research and education. Earlier this year it commissioned an industry wide drug delivery survey, and has recently launched the second annual Global Academic Competition for Life Science Leaders of Tomorrow, which encourages students’ interest and knowledge of applied drug delivery technologies.